Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.37 USD | +3.69% | +3.69% | -41.90% |
Financials (USD)
Sales 2024 * | 65.38M | Sales 2025 * | 6.25M | Capitalization | 22.45M |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | -41M | EV / Sales 2024 * | 0.34 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.59 x |
P/E ratio 2024 * |
1.03
x | P/E ratio 2025 * |
-0.58
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | +3.69% | ||
1 week | +3.69% | ||
Current month | -15.75% | ||
1 month | -12.01% | ||
3 months | -26.74% | ||
6 months | -51.93% | ||
Current year | -41.90% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 3.37 | +3.69% | 6,549 |
24-04-19 | 3.25 | 0.00% | 26,402 |
24-04-18 | 3.25 | -1.81% | 12,047 |
24-04-17 | 3.31 | +3.44% | 9,086 |
24-04-16 | 3.2 | -1.54% | 16,466 |
Delayed Quote Nasdaq, April 22, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.90% | 22.45M | |
-0.02% | 42.11B | |
+45.94% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- MEIP Stock